Eccrine Porocarcinoma

This is a very rare type of skin cancer that starts in the sweat glands. It usually develops slowly over many years from a harmless bump called an eccrine poroma. It's not common, but it's important to know about.

Condition

What people with Eccrine Porocarcinoma report

Every report comes from a Lived member, sent anonymously.

Have you had Mohs Surgery for Eccrine Porocarcinoma?

NameHow it went

About Eccrine Porocarcinoma

What It Is

Eccrine porocarcinoma is a rare skin cancer that starts in the ducts of the eccrine sweat glands, the glands that produce ordinary sweat across most of the body. It usually appears as a firm red, pink or purplish bump or patch that slowly enlarges and may itch, bleed or break open into a sore. It is found most often on the head and neck or the legs and feet. Some porocarcinomas develop from a poroma, a common benign sweat duct growth that a person may have had for years. Others arise on their own. Most are found while still confined to the skin, where surgery is usually effective. Because this cancer can return at the same spot or spread to nearby lymph nodes and, less often, to organs such as the lungs, it is treated more seriously than the most common skin cancers.

Causes & Risk Factors

The exact cause is not known. It is mainly a cancer of older adults, most often diagnosed between the ages of 60 and 80, although younger adults are occasionally affected. Long-term sun exposure appears to contribute: the tumors often carry the genetic damage typical of ultraviolet light. A weakened immune system, such as after an organ transplant or with long-term immune-suppressing medicine, raises risk. Cases have also been described in skin previously damaged by radiation or injury. Having a poroma is not a reason for alarm in itself, since most poromas stay benign, but a long-standing poroma that starts to change deserves a closer look.

How It's Diagnosed

Porocarcinoma cannot be identified by appearance alone. It can look like a benign growth, a squamous cell carcinoma, a basal cell carcinoma or even an unpigmented melanoma. Many people have the bump for years before it is diagnosed, often because it grew slowly and caused no pain. A dermatologist may examine the spot with a magnifying light called a dermatoscope, but a biopsy (removing part or all of the growth for laboratory examination) is needed to confirm it. Even under the microscope it can resemble squamous cell carcinoma, so pathologists may use special stains, and sometimes tests for gene changes typical of sweat duct tumors, to tell them apart. Once the diagnosis is made, the care team checks whether the cancer has spread. This usually starts with feeling the nearby lymph nodes and may include an ultrasound or other imaging scans. Features in the biopsy report, such as tumor depth, how quickly the cells are dividing and whether cancer cells are seen inside small blood or lymph vessels, help estimate the risk of spread.

Treatment Options

Surgery to remove the whole tumor is the main treatment and, for cancer confined to the skin, is often all that is needed. Wide local excision removes the tumor with a margin of normal-looking skin around it. Mohs surgery removes the tumor in thin layers that are checked under the microscope during the procedure until the edges are clear, which spares healthy tissue on the face and other sensitive areas. In small studies, cancer came back at the same site less often after Mohs surgery than after standard excision, but the two have never been compared in a trial. If lymph nodes are enlarged or a biopsy shows cancer in them, those nodes are usually removed. Whether to test normal-feeling nodes with a sentinel lymph node biopsy (removing the first one or two nodes the area drains to) is not settled, and specialists weigh it case by case. There are no established guidelines for treatment beyond surgery. Radiation is sometimes added when the edges of the removed tissue still contain cancer, when the tumor invades nerves, or when it returns. For cancer that has spread widely, chemotherapy has helped only a minority of people. Immunotherapy drugs that help the immune system recognize cancer, such as pembrolizumab, and targeted drugs that block a growth-signaling protein on the cancer cells have worked in individual reports, but they remain unproven for this cancer. Because few doctors see many cases, care at a center with a skin cancer team, including a surgeon, a dermatologist and a cancer specialist, is often recommended.

What to Expect

Most people whose stage is recorded are diagnosed while the cancer is still limited to the skin, and in that situation the outlook after complete removal is good. In one large U.S. registry study, about 95 to 97 percent of people with early-stage disease were alive five years later without dying from this cancer. Outcomes are less favorable when the cancer has grown deep into the skin or reached the lymph nodes (about two-thirds survived five years in the same study) and considerably worse when it has spread to distant organs. These figures come from small or older studies and cannot predict any one person's course. The main concern after surgery is that the cancer may recur at the scar or appear in nearby lymph nodes, sometimes months to years later. Follow-up usually involves regular skin and lymph node checks, sometimes with imaging. Recovery from excision or Mohs surgery is usually quick, though removal from the face, scalp or a toe may need reconstruction and a longer healing period.

When to Seek Help

See a dermatologist about any skin growth that is new and keeps enlarging, or any long-standing bump, including one previously called a poroma, that suddenly grows, bleeds without injury or turns into a sore that does not heal. If you have already been treated, contact your care team soon about a new lump at or near the scar or a swollen lymph node in the neck, armpit or groin near the treated area, rather than waiting for your next scheduled visit.

Questions to Ask Your Doctor

  1. 1.Was the whole tumor removed with clear margins, and does anything in my pathology report suggest a higher risk of recurrence or spread?
  2. 2.Do I need imaging or a lymph node biopsy to check whether the cancer has spread?
  3. 3.Would Mohs surgery or wide local excision be better for the location of my tumor, and what will the scar or reconstruction involve?
  4. 4.How often should I have follow-up visits, and what changes should I watch for between them?
  5. 5.Should my care include a specialist center or tumor board with experience in rare skin cancers?

Last reviewed • Oct 2026

Educational content, not medical advice.